Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey
Clinical Therapeutics, 2016 02; 5(2): 209-220
Authors
Lin PL, Hao Y, Xie J, Li N, Zhong Y, Zhou Z, Signorovitch JE, Wu EQ